logo

For the Inventor, By the Inventor

Seattle, WA, United States of America

Rarecyte, Inc.


USPTO Granted Patents = 60

% Expired Patents = 5.0



Trademarks = 17

Forward Citations = 172

Loading Chart...
Loading Chart...

23 inventors (with patents filed for the assignee):

goldMedal Steve Quarre (32 out of 32 patents)

silverMedal Ronald C Seubert (23 out of 24 patents)

bronzeMedal Daniel E Campton (23 out of 23 patents)

4.  Joshua Nordberg (22 out of 22 patents)

5.  David Edward Stewart (19 out of 25 patents)

6.  Lance U'Ren (17 out of 17 patents)

7.  Jonathan Lundt (9 out of 9 patents)

8.  Jennifer Chow (9 out of 9 patents)

9.  Edward Shafer (8 out of 8 patents)

10.  Arturo Bernardo Ramirez (8 out of 9 patents)

11.  Jeremy Cooper (5 out of 12 patents)

12.  Joel Smith (4 out of 4 patents)

13.  Jackie Stilwell (4 out of 4 patents)

14.  Paulina Varshavskaya (3 out of 3 patents)

15.  Melinda R Duplessis (3 out of 3 patents)


Core Competencies:
Fluorescence Imaging
Spectral Edge Detection
Analyte Detection
Automated Substrate Loading
Biomarker Labeling
Dielectrophoresis
Target Analyte Selection
Fluid Spreading
Antigen-Specific Cells
Material Harvesting
Suspension Analysis

60 patents:

1. 12222487 - Holding a substrate within a secondary device (2025-02-11),
2. 12038381 - Methods of reducing spectral crosstalk in multiplexed fluorescence imaging (2024-07-16),
3. 11719929 - Optical trains for imaging systems and spectral edge detection (2023-08-08),
4. 11692939 - Spectral edge detection (2023-07-04),
5. 11573415 - Device, system, and method for changing angle of incidence of a filter or filter wheel (2023-02-07),
6. 11422352 - Automated substrate loading (2022-08-23),
7. 11402301 - Device, system, and method for selecting a target analyte (2022-08-02),
8. 11300769 - Automated substrate loading (2022-04-12),
9. 11237377 - Apparatus for holding a substrate within a secondary device (2022-02-01),
10. 11231344 - Device, system, and method for selecting a target analyte (2022-01-25),
11. 11119106 - Analyte detection (2021-09-14),
12. 11105803 - Method to identify antigen-specific immune cells (2021-08-31),
13. 11067487 - Apparatus, system, and method for collecting a target material (2021-07-20),
14. 11054346 - Detecting a substrate (2021-07-06),
15. 10962362 - Detecting a substrate (2021-03-30),
Company Overview
Rarecyte, Inc. is a Seattle-based company specializing in advanced fluorescence imaging technologies. The organization focuses on developing innovative solutions for analyte detection, employing techniques such as spectral edge detection and biomarker labeling. Their expertise extends to automated substrate loading and dielectrophoresis, enabling precise target analyte selection and fluid spreading. Rarecyte's technologies are pivotal in enhancing the capabilities of biomedical research and diagnostics, contributing to advancements in personalized medicine and disease detection.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Rarecyte, Inc. USPTO Patent Assignee Logo
60 Patents

#44 in Seattle, WA

#125 in Washington

#5,991 in US

#12,077 in the World

Seattle, WA (US)
Seattle, WA, United States of America

Rarecyte, Inc.

Forward Citations = 172

23 inventors:

goldMedal Steve Quarre (32 out of 32 patents)

silverMedal Ronald C Seubert (23 out of 24 patents)

bronzeMedal Daniel E Campton (23 out of 23 patents)

4.  Joshua Nordberg (22 out of 22 patents)

5.  David Edward Stewart (19 out of 25 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rarecyte, Inc.. Retrieved from https://idiyas.com/company/rarecyte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…